Bausch + Lomb receives Health Canada approval of Lumify redness reliever eye drops

Bausch Health

24 May 2022 - Lumify is Canada's first and only over the counter eye drop with low dose brimonidine for the relief of eye redness.

Bausch + Lomb Corporation today announced that Health Canada has approved Lumify (brimonidine tartrate ophthalmic solution 0.025% w/v), the first and only over the counter eye drop developed with low-dose brimonidine tartrate to relieve redness of the eye due to minor eye irritations for adults.

Read Bausch & Lomb press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , Canada